Omkar Pharmachem Limited (BOM:532167)
India flag India · Delayed Price · Currency is INR
6.21
+0.12 (1.97%)
At close: Nov 13, 2026

Omkar Pharmachem Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
3.714.655.45.45.45.4
Revenue Growth
-31.37%-13.89%0%0%0%100.00%
Gross Profit
1.462.563.793.84.013.65
Operating Income
0.51.622.852.783.082.67
Net Income
0.381.222.011.891.981.83
Earnings Per Share
0.040.120.200.190.200.18
EPS Growth
-73.57%-39.77%6.24%-4.40%8.97%-18.02%

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
1.652.171.090.721.332.11
Total Debt
--1.193.036.219.3
Net Cash (Debt)
1.652.17-0.09-2.32-4.89-7.18
Net Cash Growth
175.88%-----
Net Cash Per Share
0.160.22-0.01-0.23-0.48-0.71

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
1.052.292.442.962.762.03
Capital Expenditures
---0.04-0.09--0.07
Free Cash Flow
1.052.292.42.862.761.96
Free Cash Flow Growth
-48.66%-4.59%-16.35%3.77%40.77%775.00%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
39.29%55.14%70.24%70.28%74.28%67.57%
Operating Margin
13.44%34.82%52.76%51.56%57.07%49.41%
Pretax Margin
14.25%35.01%50.00%46.81%48.98%38.98%
Profit Margin
10.31%26.19%37.20%35.02%36.63%33.91%
FCF Margin
28.33%49.14%44.35%53.02%51.09%36.30%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
168.12244.23150.58119.88127.45112.35
P/FCF Ratio
59.64130.18126.3179.1891.37104.96
PS Ratio
16.9063.9756.0241.9846.6938.10